Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-07

Clinical Trial Update: Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial investigated preoperative induction chemotherapy with capecitabine, oxaliplatin, bevacizumab, and radiotherapy for rectal cancer; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)
  • Capecitabine (capecitabine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Austrian Breast & Colorectal Cancer Study Group | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED